Joshua Meier Profile
Joshua Meier

@joshim5

Followers
6K
Following
1K
Media
80
Statuses
583

Co-Founder at Chai Discovery

San Francisco
Joined March 2009
Don't wanna be here? Send us removal request.
@joshim5
Joshua Meier
18 days
Proud to announce @ChaiDiscovery has raised a $70M Series A from @MenloVentures & Anthology Fund (@AnthropicAI), @ThriveCapital, @OpenAI + others. 🧬 Chai is an applied AI lab building frontier tools for molecular design. This funding will power our new models, coming soon👇
65
82
1K
@joshim5
Joshua Meier
4 days
Why now? Chai-2 achieves a ~20% success rate in antibody design. That's 100x better than prior methods. We’re excited to deploy this technology toward the hardest problems. Together, we can discover hundreds more molecules, unlocking a new generation of therapeutics. 🚀.
1
1
12
@grok
Grok
5 days
What do you want to know?.
348
210
1K
@joshim5
Joshua Meier
4 days
🧬 Dr. Mikael Dolsten is joining the @ChaiDiscovery board!. In 15 years as @Pfizer's Chief Scientific Officer he:.⚛️ Progressed 150 molecules to clinical trials.💊 Delivered 36 approved medicines, from vaccines to cancer therapies
4
13
107
@joshim5
Joshua Meier
11 days
RT @chaidiscovery: Find out more about the evolution of Chai-1 to Chai-2, the 200x leap in antibody design success rates, and what this mea….
0
5
0
@joshim5
Joshua Meier
11 days
🎙️ Fresh off our $70M Series A at @ChaiDiscovery, it was fun sitting down with @JacobEffron of @Redpoint to discuss Chai-2 and our recent breakthroughs in AI Drug Discovery.
@jacobeffron
Jacob Effron
11 days
New Unsupervised Learning with @joshim5 (@chaidiscovery) on how AI x drug discovery is starting to inflect and: . - The 3 waves of AI biotech. - How AI models think differently than chemists. - Building "Photoshop for molecules" . - Deciding what to open source
3
6
73
@joshim5
Joshua Meier
16 days
RT @chaidiscovery: Thank you @Nasdaq for the kind words and for lighting up Times Square! 💙. Excited to keep pushing the boundaries of mole….
0
10
0
@joshim5
Joshua Meier
17 days
Great insights from @max_a_schwarzer on the development of @OpenAI’s GPT5. Frontier AI model development is all about getting the details right, across the entire stack — data, model, algorithms, and more . We see the same @chaidiscovery.
@tbpn
TBPN
17 days
We asked @max_a_schwarzer (Researcher @OpenAI) about post-training improvements in GPT-5:. "The thing that is most impressive about GPT-5 is how much getting all of the details right matters.". "The team went off and did a deep dive of completely rebuilding the post-training
0
0
5
@joshim5
Joshua Meier
17 days
Thank you @akashpasricha for having me and @grgyap on the show.
@theinformation
The Information
17 days
.@grgyap, Partner at @MenloVentures, shares how generative AI is profoundly changing drug discovery:. "It offers you the potential to create new molecules that have never been thought of by humans before.". "Now you have an opportunity to. make a drug by seeing inside the lock,
0
0
8
@joshim5
Joshua Meier
17 days
RT @theinformation: .@grgyap, Partner at @MenloVentures, shares how generative AI is profoundly changing drug discovery:. "It offers you th….
0
7
0
@joshim5
Joshua Meier
18 days
RT @saranormous: .@chaidiscovery is *the* AI lab transforming end-to-end biological discovery into an engineering problem. investor from….
0
4
0
@joshim5
Joshua Meier
18 days
Read more from the @FinancialTimes here:
@fttechnews
FT Technology News
18 days
OpenAI-backed Chai raises $70mn for AI-driven drug discovery
0
0
16
@joshim5
Joshua Meier
18 days
We’re grateful for the support of our Series A investors @MenloVentures @ThriveCapital @OpenAI Yosemite DST @SVAngel Avenir @DCVC @_DimensionCap @Neo @LachyGroom @FEhrsam, and many others. More about our funding:
Tweet card summary image
chaidiscovery.com
Building frontier artificial intelligence to predict and reprogram the interactions between biochemical molecules.
1
0
21
@joshim5
Joshua Meier
18 days
A meaningful fraction of the biotech industry has already applied for Chai-2 access. We’re excited to bring this technology to our partners. Learn more & apply for early access at
chaidiscovery.com
Building frontier artificial intelligence to predict and reprogram the interactions between biochemical molecules.
1
0
22
@joshim5
Joshua Meier
18 days
🧬 To help deploy our technology, Dr. Mikael Dolsten is joining the Chai Discovery board. In 15 years as @Pfizer's Chief Scientific Officer he:. ✅Progressed 150 molecules to clinical trials.✅Delivered 36 approved medicines, from vaccines to cancer therapies.
1
1
33
@joshim5
Joshua Meier
18 days
🧑‍🔬Chai-2 delivers de novo antibody design with a >15% hit rate (vs. 0.1% for previous AI methods). 🏆One group spent 3+ years and $5M on a tough target. With Chai-2 we delivered an experimentally validated binder in just two weeks.
@chaidiscovery
Chai Discovery
2 months
We’re excited to introduce Chai-2, a major breakthrough in molecular design. Chai-2 enables zero-shot antibody discovery in a 24-well plate, exceeding previous SOTA by >100x. Thread👇
1
0
33
@joshim5
Joshua Meier
18 days
Weeks ago, we launched Chai-2, a major leap forward in molecular design. Chai-2 enables us to design antibodies from scratch, entirely on the computer.
Tweet media one
1
1
42
@joshim5
Joshua Meier
18 days
Chai’s mission is to transform biology from science into engineering to unlock entirely new frontiers in medicine. With Chai-1, we delivered the ability to see the structure of molecules. Now with Chai-2, we have unlocked the ability to design and create them.
1
0
42
@joshim5
Joshua Meier
22 days
RT @OracleCloud: 🔬 Accelerating scientific breakthroughs with OCI. @chaidiscovery leveraged OCI to support the adv….
0
13
0
@joshim5
Joshua Meier
1 month
RT @chaidiscovery: 🎉 Congratulations to @ZhuoranQ for winning the Chen Institute and @ScienceMagazine AI Prize, recognizing his groundbreak….
0
4
0
@joshim5
Joshua Meier
2 months
Chai-2 is now up on BioRxiv:
Tweet card summary image
biorxiv.org
Despite breakthroughs in protein design enabled by artificial intelligence, reliably designing functional antibodies from scratch has remained an elusive challenge. Recent works show promise but...
@BiologyAIDaily
Biology+AI Daily
2 months
Zero-shot antibody design in a 24-well plate @chaidiscovery. 1. Researchers have introduced Chai-2, a multimodal generative model that marks a significant leap in de novo antibody and miniprotein design. This platform achieves an impressive 16% hit rate in de novo antibody
Tweet media one
3
25
188